Bon ap­petit: Cel­lec­tis CEO Chouli­ka hosts a gene-edit­ed feast; CRO Med­pace adding 650 staffers

Cel­lec­tis CEO An­dré Chouli­ka loves noth­ing bet­ter than cel­e­brat­ing the pi­o­neer­ing work he’s plan­ning to do with gene edit­ing and next-gen CAR-T. But he al­so runs an ag bio out­fit called Ca­lyxt which plans to bring the gene edit­ing rev­o­lu­tion in­to the food sup­ply. And what bet­ter way to high­light that work than the world’s first feast in­volv­ing gene-edit­ed foods. Ac­cord­ing to the PR, the din­ner in New York re­quired “a six-month prepa­ra­tion time en­trust­ed to The Lab-Ducasse Con­seil’s chefs and ex­perts with a se­ries of tri­als where the in­gre­di­ents were cooked and tast­ed in a va­ri­ety of ways. At­ten­dees in­clud­ed uni­ver­si­ty pro­fes­sors, doc­tors, re­porters, celebri­ties, en­tre­pre­neurs and key opin­ion lead­ers.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.